Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients With Migraine: Results From Two Global Phase 3 Clinical Trials

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.04.1413
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy